olmesartan medoxomil has been researched along with Aneurysm, Aortic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoka, Y; Aomi, S; Hagiwara, N; Kasanuki, H; Kawana, M; Nagashima, H; Sakomura, Y; Sakuta, A; Uto, K | 1 |
1 other study(ies) available for olmesartan medoxomil and Aneurysm, Aortic
Article | Year |
---|---|
An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats.
Topics: Aminopropionitrile; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Aneurysm; Aortic Dissection; Disease Models, Animal; Imidazoles; Olmesartan Medoxomil; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Thiazepines | 2002 |